CARLSBAD, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it will showcase its product portfolio at the upcoming EuroSpine 2014 meeting, which is being held in Lyon, France, from October 1st to October 3rd, 2014. Alphatec Spine will be located in booth number B18 at the Cité Internationale Centre des Congrès and will host a workshop entitled, "Less Invasive Solutions – Complex Spine Pathology" on October 2nd, 2014.
This year Alphatec Spine will be showcasing key products from all of its major portfolio segments including, MIS, Thoracolumbar, Interbody, Cervical and Biologics. Key products that will be highlighted in Alphatec Spine's booth and workshops will include the ILLICO® Multi-Level MIS system, the OsseoScrew® spinal fixation system, the Zodiac® DVR (Direct Vertebral Rotation) Deformity system, the DiscoCerv® artificial disc system, the Trestle Luxe® Anterior Cervical Plating system and the BridgePoint® MIS spinous process fixation system. Additionally, the Company will also be highlighting several of its Biologics products that are designed to be integrated in a surgical procedure to aid in fusion.
"EuroSpine 2014 is a venue where key thought leaders, researchers and surgeons from around the world gather to discuss new developments in the treatment of spinal disorders and related conditions," said Jim Corbett, President and CEO of Alphatec Spine. "We look forward to engaging in the exchange of research and innovation, while showcasing our broad, global portfolio of spinal fusion technologies. With over one-third of our business based internationally, EuroSpine provides an opportunity for us to engage new customers and deepen our existing international relationships as we focus on our goal of profitably growing our global business."
In addition, on Thursday, October 2nd at 12:00pm in Room Bellecour 1 on Level 1, Alphatec Spine will be hosting a workshop entitled, "Less Invasive Solutions – Complex Spine Pathology", featuring presentations and facilitation by key thought leaders in spinal surgery: Mr. Michael Wong, neurosurgeon and spinal surgeon at the Royal Melbourne Hospital in Australia, hands-on participation under the facilitation of Dr. Gad Velan, Chief of Spine Surgery at The Soroka Medical Center in Israel, and Prof. Nikolai Gabrovsky, Head of the Department of Neurosurgery at Hospital Pirogov in Bulgaria.
EuroSpine, the Spine Society of Europe, was founded in June 26, 1998, in Innsbruck, Austria. The purpose of EuroSpine is to provide a platform in European countries for the exchange of knowledge and ideas in the field of research, prevention, and treatment of spine diseases.
For more information about EuroSpine 2014, please visit: www.eurospine2014.eu.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global provider of spinal fusion technologies for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: Alphatec Spine's ability to continue to profitably grow its global business; the acceptance of Alphatec Spine's and its affiliate's products by the international surgeon community, including without limitation the products discussed in this press release. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact: Christine Zedelmayer Investor Relations Alphatec Spine, Inc. (760) 494-6610 email@example.com
Source:Alphatec Holdings, Inc.